证券代码：000609 证券简称：ST 中迪 公告编号：2025-109 北京中迪投资股份有限公司 关于公司股票交易异常波动的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、股票交易异常波动的情况介绍 北京中迪投资股份有限公司股票（股票代码：000609，证券简称：ST 中迪） 于 2025 年 8 月 20 日、8 月 21 日、8 月 22 日连续 3 个交易日收盘价格涨幅偏离 值累计达到 13.64%，根据《深圳证券交易所交易规则》的有关规定，属于股票 交易异常波动的情况。 二、公司核实情况说明 针对公司股票异常波动，公司对有关事项进行了核查，说明如下： 1、公司前期披露的信息不存在需要更正、补充之处。 2、公司未发现近期公共传媒报道可能或已经对本公司股票交易价格产生较 大影响的未公开重大信息。 3、近期公司经营情况正常，内外部经营环境未发生重大变化。 4、公司、控股股东和实际控制人不存在关于本公司的应披露而未披露的重 大事项，或处于筹划阶段的重大事项。 5、股票异常波动期间控股股东、实际控制人未买卖公司股票。 三、是否存在应披露而未披露信息的说明 ...

Core Viewpoint - ST Zhongdi (000609) reported a significant decline in financial performance for the first half of 2025, with total revenue dropping by 52.39% year-on-year and a net loss of 84.84 million yuan, indicating ongoing operational challenges and increased financial burdens [1] Financial Performance Summary - Total revenue for the reporting period was 134 million yuan, a decrease of 52.39% year-on-year [1] - Net profit attributable to shareholders was -84.84 million yuan, down 13.53% year-on-year [1] - Gross margin was 0.1%, a decline of 89.85% year-on-year, while net margin was -63.36%, down 138.48% year-on-year [1] - Total expenses (selling, administrative, and financial) reached 80.62 million yuan, accounting for 60.21% of total revenue, an increase of 160.28% year-on-year [1] - Earnings per share were -0.28 yuan, a decrease of 12.0% year-on-year [1] Changes in Financial Items - Contract liabilities decreased by 18.93% due to the completion and delivery of certain projects, leading to revenue recognition [2] - Long-term borrowings decreased by 100% as they were reclassified to current liabilities [2] - Other payables increased by 25.45% due to overdue interest on loans [2] - Revenue and cost of goods sold both decreased by 52.39% and 51.99% respectively, attributed to reduced project completions [2] Cash Flow and Financial Health - Net cash flow from operating activities decreased by 48.24%, primarily due to increased payments for construction [4] - Net cash flow from investing activities dropped by 99.03%, with no significant investment recoveries during the period [4] - Net cash flow from financing activities increased by 97.21%, reflecting higher financial support from related companies [4] Business Evaluation - The company's historical return on invested capital (ROIC) has been poor, with a median of -5.28% over the past decade and a worst year ROIC of -15.13% in 2021 [4] - The company has reported losses in 6 out of 28 annual reports since its listing, indicating a challenging financial history [4] Financial Health Indicators - Cash flow situation is concerning, with cash and cash equivalents to current liabilities at only 4.33% [5] - Debt situation is critical, with interest-bearing debt ratio at 37.11% and total interest-bearing liabilities to average operating cash flow at 20.68% [5] - Financial expenses are high, with financial expenses to average operating cash flow at 328.9% [5] - Inventory levels are excessive, with inventory to revenue ratio at 522.29% [5]

Performance Disclosure - Muyuan Foods reported a revenue of 76.463 billion yuan for the first half of 2025, representing a year-on-year increase of 34.46%, with a net profit attributable to shareholders of 10.53 billion yuan, up 1169.77% year-on-year [1] - Shanghai Petrochemical reported a revenue of 39.52 billion yuan for the first half of 2025, a year-on-year decrease of 9.2%, with a net loss attributable to shareholders of 462 million yuan, transitioning from profit to loss [2] - Fuhuan Microelectronics reported a revenue of 688 million yuan for the first half of 2025, a year-on-year decrease of 14.04%, with a net profit attributable to shareholders of approximately 23.02 million yuan, down 78.1% year-on-year [3] Shareholding Changes - Botao Bio announced that its actual controller, Yu Xiuping, plans to reduce holdings by no more than 3% of the company's total shares, equating to approximately 4.48 million shares [4] - Sanbo Brain Science announced that shareholder TBP 3Doctors (HK) Limited plans to reduce holdings by no more than approximately 609,000 shares, accounting for 3% of the total share capital after excluding shares in the repurchase account [5] - Xiangshan Co. announced that two shareholders, Zhao Yukun and Chen Bo, reduced their holdings by a total of 5.45% of the company's shares, equating to 7.1996 million shares, with the reduction plan completed [6] Risk Matters - ST Zhongdi announced that 23.77% of the shares held by its controlling shareholder, totaling 71.1448 million shares, will be publicly auctioned from September 24 to 25, 2025, due to debt disputes, which may lead to a change in company control if the auction is successful [7] - Kailong Co. announced that its subsidiaries were fined a total of 1.762 million yuan for reaching a fixed price monopoly agreement, which is expected to reduce the company's net profit by approximately 1.3962 million yuan [8] - Tiansheng New Materials reported that Baoding Weishai New Materials Technology Co., Ltd. filed an appeal involving an amount of 802 million yuan, seeking to overturn a previous court ruling [9]

Performance Disclosure - Muyuan Foods reported a revenue of 76.463 billion yuan for the first half of 2025, representing a year-on-year increase of 34.46%, with a net profit attributable to shareholders of 10.53 billion yuan, up 1169.77% year-on-year [1] - Shanghai Petrochemical reported a revenue of 39.52 billion yuan for the first half of 2025, a year-on-year decrease of 9.2%, with a net loss attributable to shareholders of 462 million yuan, transitioning from profit to loss [2] - Fuhuan Microelectronics reported a revenue of 688 million yuan for the first half of 2025, a year-on-year decrease of 14.04%, with a net profit attributable to shareholders of approximately 23.02 million yuan, down 78.1% year-on-year [3] Shareholding Changes - Botao Biological announced that its actual controller, Yu Xiuping, plans to reduce holdings by no more than 3% of the company's total shares, equating to approximately 4.48 million shares [4] - Sanbo Brain Science announced that shareholder TBP 3Doctors (HK) Limited plans to reduce holdings by no more than approximately 609,000 shares, representing 3% of the total share capital after excluding shares in the repurchase account [5] - Xiangshan Co. announced that two shareholders, Zhao Yukun and Chen Bo, reduced their holdings by a total of 5.45% of the company's shares, equating to 7.1996 million shares, with the reduction plan completed [6] Risk Matters - ST Zhongdi announced that 23.77% of the shares held by its controlling shareholder, totaling 71.1448 million shares, will be publicly auctioned from September 24 to 25, 2025, due to debt disputes, which may lead to a change in company control [7] - Kailong Co. announced that its subsidiaries were fined a total of 1.762 million yuan for reaching a fixed price monopoly agreement, which is expected to reduce the company's net profit by approximately 1.3962 million yuan [8] - Tiansheng New Materials reported that Baoding Weishai New Materials Technology Co., Ltd. filed an appeal involving an amount of 802 million yuan, seeking to overturn a previous court ruling [9]

证券代码：000609 证券简称：ST 中迪 公告编号：2025-108 北京中迪投资股份有限公司 关于控股股东所持股份将被司法拍卖的提示性公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 特别风险提示： 1、北京中迪投资股份有限公司（以下简称"公司"、"中迪投资"）控股股东 广东润鸿富创科技中心（有限合伙）（以下简称"润鸿富创"）持有的 71,144,800 股公司股票（股份性质为无限售流通股）占其持有本公司股份总数的 100%，占 公司总股本的 23.77%，将于 2025 年 9 月 24 日 10:00 时起至 2025 年 9 月 25 日 10:00 时 止 （ 即 24 小 时 ， 延 时 除 外 ） 在 " 阿 里 资 产 · 司 法 " （https://sf-item.taobao.com）进行公开拍卖。 2、公司实际控制人为吴珺，控股股东为广东润鸿富创科技中心（有限合伙）。 若本次拍卖成功，存在公司控制权发生变更的风险。 3、本次司法拍卖事项尚处于拍卖公示阶段，根据相关规定，法院有权在拍 卖开始前、拍卖过程中中止拍卖或撤回拍卖，后续可能涉 ...

Core Viewpoint - ST Zhongdi (000609) announced that its controlling shareholder, Runhong Fuchuang, will auction 71.1448 million shares, representing 23.77% of the company's total equity, due to debt disputes, which may lead to a change in control of the company [1] Group 1 - The auction is scheduled to take place from September 24 to 25, 2025, on Alibaba Assets Judicial platform [1] - As of June 30, 2025, the company's wholly-owned subsidiary, Zhongmei Heng Real Estate, owes a total of 564 million yuan in principal, interest, penalties, and compound interest to the Sanxia Bank [1] - The auction is currently in the public notice stage, and subsequent steps may involve bidding, payment, and transfer of equity, with uncertain outcomes [1]

（文章来源：证券日报） 证券日报网讯 8月19日晚间，华远控股发布公告称，公司将于2025年9月5日召开2025年第二次临时股东 会。本次股东会将审议《关于增补第八届董事会非独立董事的议案》等。 ...

Group 1 - The core viewpoint of the article is that ST Zhongdi (000609.SZ) reported a significant decline in revenue and net profit for the first half of 2025, indicating financial distress [1] Group 2 - The company achieved an operating income of 134 million yuan in the first half of 2025, representing a year-on-year decrease of 52.39% [1] - The net profit attributable to shareholders of the listed company was -84.8467 million yuan [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -80.6950 million yuan [1] - The basic earnings per share were -0.28 yuan [1]

ST中迪（SZ 000609，收盘价：3.3元）8月19日晚间发布公告称，公司第十一届第一次董事会会议于 2025年8月19日以通讯方式召开。会议审议了《关于选举公司董事长的议案》等文件。 2024年1至12月份，ST中迪的营业收入构成为：房地产行业占比99.97%，其他业务占比0.03%。 （文章来源：每日经济新闻） ...

ST中迪（SZ 000609，收盘价：3.3元）8月19日晚间发布半年度业绩报告称，2025年上半年营业收入约 1.34亿元，同比减少52.39%；归属于上市公司股东的净利润亏损约8485万元；基本每股收益亏损0.28 元。2024年同期营业收入约2.81亿元；归属于上市公司股东的净利润亏损约7474万元；基本每股收益亏 损0.25元。 （文章来源：每日经济新闻） ...